Factors influencing nerve regeneration in a trial of timcodar dimesylate

Research output: Contribution to journalArticlepeer-review

Abstract

The authors assessed the ability of the neurophilin compound, timcodar dimesylate, to accelerate the return of epidermal nerve fiber density (ENFD) after a standardized nerve injury in a randomized double blind, placebo controlled trial. While there was no difference in the regeneration rate between the treatment and placebo arms, the baseline ENFD (p = 0.006), height (p = 0.02), and race (p = 0.03) were associated with the regeneration rate.

Original languageEnglish (US)
Pages (from-to)259-261
Number of pages3
JournalNeurology
Volume66
Issue number2
DOIs
StatePublished - Jan 2006

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Factors influencing nerve regeneration in a trial of timcodar dimesylate'. Together they form a unique fingerprint.

Cite this